NCT00195403View on ClinicalTrials.gov

A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA

CompletedOBSERVATIONAL

Enrollment

1,014

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Etanercept

Etanercept 25mg Injection, 2 times/week

Trial Locations (4)

463-712

Kyunggi-do

120-752

Seoul

133-792

Seoul

137-807

Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY